Associate Director, Digital and Omnichannel Marketing at Corcept Therapeutics

Redwood City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, Oncology, HealthcareIndustries

Requirements

Experience leading digital and omnichannel marketing strategies, particularly in pharmaceuticals or oncology
Ability to develop and operationalize digital engagement models for personalized customer experiences
Strong collaboration skills with cross-functional teams (Commercial, Medical Affairs, Market Access, Insights & Analytics, IT, Sales Leadership)
Expertise in designing, implementing, and optimizing omnichannel campaigns using marketing technology stacks
Proficiency in audience targeting, activation, and optimization of automated customer journeys
Knowledge of defining user and business requirements for marketing technologies, ensuring integration and alignment
Current awareness of digital and omnichannel innovations in the pharmaceutical industry
Experience designing customer journey maps (HCP, Patient) based on insights and brand objectives
Ability to manage media agency partners for campaigns across search, display, social, and programmatic channels
Skills in monitoring performance, channel optimization, and delivering data-driven reports to stakeholders

Responsibilities

Lead development and implementation of omnichannel marketing plans driving individualized customer engagement, collaborating with HCP and Patient Marketing and aligning with Sales Leadership
Serve as the marketing lead for omnichannel governance and cross-organizational coordination
Design and deploy omnichannel campaigns leveraging the technology stack, partnering with Insights and Analytics for audience targeting, activation, and optimization
Ensure data-driven, timely, and compliant campaign execution enhancing customer engagement and brand impact
Lead the process for defining user and business requirements for the marketing technology stack, aligning tools, processes, and timelines
Collaborate with Insights and Analytics to integrate marketing technologies supporting campaign execution
Remain current with digital and omnichannel innovations, proactively piloting and scaling new approaches
Partner with Insights & Analytics to design and optimize customer journeys, developing journey maps (HCP, Patient), communicating insights to Oncology Leadership, and supporting cross-functional optimization
Manage media agency partners to develop and execute campaigns across search, display, social, and programmatic channels aligned to omnichannel strategy
Monitor performance across channels, devise optimization strategies using data-driven insights, and deliver regular reports to senior stakeholders

Skills

Digital Marketing

Omnichannel Marketing

Oncology Marketing

Launch Strategy

Customer Engagement

HCP Marketing

Patient Marketing

Cross-functional Collaboration

Marketing Analytics

Strategy Development

Corcept Therapeutics

Develops cortisol modulators for medical conditions

About Corcept Therapeutics

Corcept Therapeutics focuses on developing treatments that regulate cortisol levels in the body, which is important for managing various health issues. Their main product, Korlym, is used to treat Cushing's syndrome, a condition caused by too much cortisol. Korlym was approved by the FDA in 2012 and is the first medication specifically for this disorder. Corcept stands out from competitors by having a strong emphasis on research and development, having discovered over 1,000 unique cortisol modulators. The company aims to expand its range of treatments while also providing educational resources to healthcare professionals and patients to improve understanding and care for cortisol-related conditions.

Menlo Park, CaliforniaHeadquarters

1998Year Founded

$39.7MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Remote Work Options

Flexible Work Hours

Risks

Teva's antitrust lawsuit could lead to legal expenses and market share loss.

Heavy reliance on Korlym makes Corcept vulnerable to market fluctuations.

Recent investments may pressure Corcept for short-term financial performance, impacting R&D.

Differentiation

Corcept specializes in cortisol modulation, a niche with few direct competitors.

Korlym is the first FDA-approved treatment for Cushing's syndrome, a significant market advantage.

Corcept's extensive R&D has led to the discovery of over 1,000 selective cortisol modulators.

Upsides

Increased interest in cortisol therapies for mental health boosts Corcept's R&D prospects.

Advancements in drug delivery systems could enhance Corcept's product efficacy.

The FDA's fast-track designation supports Corcept's innovative cortisol-related treatments.

Land your dream remote job 3x faster with AI

Try Jobo Free